Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy

Detalhes bibliográficos
Autor(a) principal: Barthélémy, Inês
Data de Publicação: 2014
Outros Autores: Mariz, Fernanda Pinto, Yada, Erica, Desquilbet, Loïc, Savino, Wilson, Barbosa, Suse Dayse Silva, Faussat, Anne-Marie, Mouly, Vincent, Voit, Thomas, Blot, Stéphane, Butler-Browne, Gillian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/10676
Resumo: Université Paris-Est. Ecole Nationale Vétérinaire d’Alfort. UPR de Neurobiologie. Paris, France.
id CRUZ_748ee26947a477030acf3d5f6ff5396e
oai_identifier_str oai:www.arca.fiocruz.br:icict/10676
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Barthélémy, InêsMariz, Fernanda PintoYada, EricaDesquilbet, LoïcSavino, WilsonBarbosa, Suse Dayse SilvaFaussat, Anne-MarieMouly, VincentVoit, ThomasBlot, StéphaneButler-Browne, Gillian2015-06-08T14:01:46Z2015-06-08T14:01:46Z2014BARTHÉLÉMY, Inès et al. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Disease Models & Mechanisms, v.7, n.11, p.1253-1261, 2014.1754-8403https://www.arca.fiocruz.br/handle/icict/1067610.1242/dmm.016014engThe Company of Biologists LtdLinfócitosGRMDDMDDistrophinPredictive biomakerLymphocyteCD49dGait analysisAccelerometryAcelerometriaDystrophinPredictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversité Paris-Est. Ecole Nationale Vétérinaire d’Alfort. UPR de Neurobiologie. Paris, France.Université Pierre et Marie Curie-Paris. Institut de Myologie. Paris, France/ Universidade Federal do Rio de Janeiro. Instituto de Pediatria. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil.Université Pierre et Marie Curie-Paris . Institut de Myologie. Paris, France.Université Paris-Est. Ecole Nationale Vétérinaire d’Alfort. Unité D’Épidémiologie clinique et de Biostatistique. Paris, France / CNRS UMR 7179, MNHN, Brunoy 91800, France.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil.Instituto Nacional de Câncer (INCA). Departamento de Pesquisa Clínica. Rio de Janeiro, RJ, Brasil.Université Pierre et Marie Curie-Paris . Institut de Myologie. Paris, France.Université Pierre et Marie Curie-Paris . Institut de Myologie. Paris, France.Université Paris-Est. Ecole Nationale Vétérinaire d’Alfort. UPR de Neurobiologie. Paris, France.Université Pierre et Marie Curie-Paris . Institut de Myologie. Paris, France.In the translational process of developing innovative therapies for DMD (Duchenne muscular dystrophy), the last preclinical validation step is often carried out in the most relevant animal model of this human disease, namely the GRMD (Golden Retriever muscular dystrophy) dog. The disease in GRMD dogs mimics human DMD in many aspects, including the inter-individual heterogeneity. This last point can be seen as a drawback for an animal model but is inherently related to the disease in GRMD dogs closely resembling that of individuals with DMD. In order to improve the management of this inter-individual heterogeneity, we have screened a combination of biomarkers in sixty-one 2-month-old GRMD dogs at the onset of the disease and a posteriori we addressed their predictive value on the severity of the disease. Three non-invasive biomarkers obtained at early stages of the disease were found to be highly predictive for the loss of ambulation before 6 months of age. An elevation in the number of circulating CD4+CD49dhi T cells and a decreased stride frequency resulting in a reduced spontaneous speed were found to be strongly associated with the severe clinical form of the disease. These factors can be used as predictive tests to screen dogs to separate them into groups with slow or fast disease progression before their inclusion into a therapeutic preclinical trial, and therefore improve the reliability and translational value of the trials carried out on this invaluable large animal model. These same biomarkers have also been described to be predictive for the time to loss of ambulation in boys with DMD, strengthening the relevance of GRMD dogs as preclinical models of this devastating muscle disease.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1914https://www.arca.fiocruz.br/bitstream/icict/10676/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINALfernanda_marizetal_IOC_2014.pdfapplication/pdf928634https://www.arca.fiocruz.br/bitstream/icict/10676/2/fernanda_marizetal_IOC_2014.pdfbea5c3f8ed6d81901b351d7c4243f0b8MD52TEXTfernanda_marizetal_IOC_2014.pdf.txtfernanda_marizetal_IOC_2014.pdf.txtExtracted texttext/plain51342https://www.arca.fiocruz.br/bitstream/icict/10676/3/fernanda_marizetal_IOC_2014.pdf.txt665a827bb53e7d2858f03c801d1e871cMD53icict/106762022-06-24 12:17:38.162oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-06-24T15:17:38Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
title Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
spellingShingle Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
Barthélémy, Inês
Linfócitos
GRMD
DMD
Distrophin
Predictive biomaker
Lymphocyte
CD49d
Gait analysis
Accelerometry
Acelerometria
Dystrophin
title_short Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
title_full Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
title_fullStr Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
title_full_unstemmed Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
title_sort Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
author Barthélémy, Inês
author_facet Barthélémy, Inês
Mariz, Fernanda Pinto
Yada, Erica
Desquilbet, Loïc
Savino, Wilson
Barbosa, Suse Dayse Silva
Faussat, Anne-Marie
Mouly, Vincent
Voit, Thomas
Blot, Stéphane
Butler-Browne, Gillian
author_role author
author2 Mariz, Fernanda Pinto
Yada, Erica
Desquilbet, Loïc
Savino, Wilson
Barbosa, Suse Dayse Silva
Faussat, Anne-Marie
Mouly, Vincent
Voit, Thomas
Blot, Stéphane
Butler-Browne, Gillian
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barthélémy, Inês
Mariz, Fernanda Pinto
Yada, Erica
Desquilbet, Loïc
Savino, Wilson
Barbosa, Suse Dayse Silva
Faussat, Anne-Marie
Mouly, Vincent
Voit, Thomas
Blot, Stéphane
Butler-Browne, Gillian
dc.subject.other.pt_BR.fl_str_mv Linfócitos
topic Linfócitos
GRMD
DMD
Distrophin
Predictive biomaker
Lymphocyte
CD49d
Gait analysis
Accelerometry
Acelerometria
Dystrophin
dc.subject.en.pt_BR.fl_str_mv GRMD
DMD
Distrophin
Predictive biomaker
Lymphocyte
CD49d
Gait analysis
Accelerometry
dc.subject.decs.pt_BR.fl_str_mv Acelerometria
Dystrophin
description Université Paris-Est. Ecole Nationale Vétérinaire d’Alfort. UPR de Neurobiologie. Paris, France.
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2015-06-08T14:01:46Z
dc.date.available.fl_str_mv 2015-06-08T14:01:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BARTHÉLÉMY, Inès et al. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Disease Models & Mechanisms, v.7, n.11, p.1253-1261, 2014.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/10676
dc.identifier.issn.pt_BR.fl_str_mv 1754-8403
dc.identifier.doi.pt_BR.fl_str_mv 10.1242/dmm.016014
identifier_str_mv BARTHÉLÉMY, Inès et al. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Disease Models & Mechanisms, v.7, n.11, p.1253-1261, 2014.
1754-8403
10.1242/dmm.016014
url https://www.arca.fiocruz.br/handle/icict/10676
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv The Company of Biologists Ltd
publisher.none.fl_str_mv The Company of Biologists Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/10676/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/10676/2/fernanda_marizetal_IOC_2014.pdf
https://www.arca.fiocruz.br/bitstream/icict/10676/3/fernanda_marizetal_IOC_2014.pdf.txt
bitstream.checksum.fl_str_mv 7d48279ffeed55da8dfe2f8e81f3b81f
bea5c3f8ed6d81901b351d7c4243f0b8
665a827bb53e7d2858f03c801d1e871c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324974627323904